177 related articles for article (PubMed ID: 25644856)
1. Salsalate treatment improves glycemia without altering adipose tissue in nondiabetic obese hispanics.
Alderete TL; Sattler FR; Richey JM; Allayee H; Mittelman SD; Sheng X; Tucci J; Gyllenhammer LE; Grant EG; Goran MI
Obesity (Silver Spring); 2015 Mar; 23(3):543-51. PubMed ID: 25644856
[TBL] [Abstract][Full Text] [Related]
2. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.
Koska J; Ortega E; Bunt JC; Gasser A; Impson J; Hanson RL; Forbes J; de Courten B; Krakoff J
Diabetologia; 2009 Mar; 52(3):385-93. PubMed ID: 19104769
[TBL] [Abstract][Full Text] [Related]
3. A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance.
Goldfine AB; Conlin PR; Halperin F; Koska J; Permana P; Schwenke D; Shoelson SE; Reaven PD
Diabetologia; 2013 Apr; 56(4):714-23. PubMed ID: 23370525
[TBL] [Abstract][Full Text] [Related]
4. Salsalate improves glycemia and inflammatory parameters in obese young adults.
Fleischman A; Shoelson SE; Bernier R; Goldfine AB
Diabetes Care; 2008 Feb; 31(2):289-94. PubMed ID: 17959861
[TBL] [Abstract][Full Text] [Related]
5. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.
Goldfine AB; Silver R; Aldhahi W; Cai D; Tatro E; Lee J; Shoelson SE
Clin Transl Sci; 2008 May; 1(1):36-43. PubMed ID: 19337387
[TBL] [Abstract][Full Text] [Related]
6. Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes.
Faghihimani E; Aminorroaya A; Rezvanian H; Adibi P; Ismail-Beigi F; Amini M
Acta Diabetol; 2013 Aug; 50(4):537-43. PubMed ID: 21938543
[TBL] [Abstract][Full Text] [Related]
7. Salsalate has no effect on insulin secretion but decreases insulin clearance: a randomized, placebo-controlled trial in subjects without diabetes.
Penesova A; Koska J; Ortega E; Bunt JC; Bogardus C; de Courten B
Diabetes Obes Metab; 2015 Jun; 17(6):608-612. PubMed ID: 25683256
[TBL] [Abstract][Full Text] [Related]
8. Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study.
Kim SH; Liu A; Ariel D; Abbasi F; Lamendola C; Grove K; Tomasso V; Ochoa H; Reaven G
Diabetes Care; 2014 Jul; 37(7):1944-50. PubMed ID: 24963111
[TBL] [Abstract][Full Text] [Related]
9. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).
Goldfine AB; Buck JS; Desouza C; Fonseca V; Chen YD; Shoelson SE; Jablonski KA; Creager MA;
Diabetes Care; 2013 Dec; 36(12):4132-9. PubMed ID: 24130358
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans.
Pierce GL; Lesniewski LA; Lawson BR; Beske SD; Seals DR
Circulation; 2009 Mar; 119(9):1284-92. PubMed ID: 19237660
[TBL] [Abstract][Full Text] [Related]
11. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial.
Goldfine AB; Fonseca V; Jablonski KA; Chen YD; Tipton L; Staten MA; Shoelson SE;
Ann Intern Med; 2013 Jul; 159(1):1-12. PubMed ID: 23817699
[TBL] [Abstract][Full Text] [Related]
12. Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes.
Faghihimani E; Aminorroaya A; Rezvanian H; Adibi P; Ismail-Beigi F; Amini M
Endocr Pract; 2012; 18(6):826-33. PubMed ID: 22784842
[TBL] [Abstract][Full Text] [Related]
13. Effect of Targeting Inflammation With Salsalate: The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins.
Hauser TH; Salastekar N; Schaefer EJ; Desai T; Goldfine HL; Fowler KM; Weber GM; Welty F; Clouse M; Shoelson SE; Goldfine AB;
JAMA Cardiol; 2016 Jul; 1(4):413-23. PubMed ID: 27438317
[TBL] [Abstract][Full Text] [Related]
14. Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls.
Trnovská J; Šilhavý J; Kuda O; Landa V; Zídek V; Mlejnek P; Šimáková M; Strnad H; Škop V; Oliyarnyk O; Kazdová L; Haluzík M; Pravenec M
PLoS One; 2017; 12(6):e0179063. PubMed ID: 28586387
[TBL] [Abstract][Full Text] [Related]
15. Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individuals.
Ariel D; Kim SH; Liu A; Abbasi F; Lamendola CA; Grove K; Tomasso V; Reaven GM
J Clin Lipidol; 2015; 9(5):658-63. PubMed ID: 26350812
[TBL] [Abstract][Full Text] [Related]
16. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.
Goldfine AB; Fonseca V; Jablonski KA; Pyle L; Staten MA; Shoelson SE;
Ann Intern Med; 2010 Mar; 152(6):346-57. PubMed ID: 20231565
[TBL] [Abstract][Full Text] [Related]
17. Salsalate improves glycaemia in overweight persons with diabetes risk factors of stable statin-treated cardiovascular disease: A 30-month randomized placebo-controlled trial.
Salastekar N; Desai T; Hauser T; Schaefer EJ; Fowler K; Joseph S; Shoelson SE; Goldfine AB;
Diabetes Obes Metab; 2017 Oct; 19(10):1458-1462. PubMed ID: 28295931
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions.
Meex RC; Phielix E; Moonen-Kornips E; Schrauwen P; Hesselink MK
J Clin Endocrinol Metab; 2011 May; 96(5):1415-23. PubMed ID: 21289240
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.
Stanley TL; Zanni MV; Johnsen S; Rasheed S; Makimura H; Lee H; Khor VK; Ahima RS; Grinspoon SK
J Clin Endocrinol Metab; 2011 Jan; 96(1):E146-50. PubMed ID: 21047923
[TBL] [Abstract][Full Text] [Related]
20. Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women--the effect of body weight reduction by caloric restriction.
Golubović MV; Dimić D; Antić S; Radenković S; Djindjić B; Jovanović M
Vojnosanit Pregl; 2013 Mar; 70(3):284-91. PubMed ID: 23607240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
